Beste apotheek van Nederland

Katlowitz N M, Albano G J, Morales P et al. Potentiation of
drug-induced erection with audiovisual sexual stimulation.
Urology 1993;41(5):431-434.
Katlowitz N, Albano G J, Patsias G et al. Effect of multidose
intracorporeal injection and audiovisual sexual stimulation in
vasculogenic impotence. Urology 1993;42(6):695-697.
Kim J M, Joh Y D, Huh J D et al. Doppler sonography of the
penile cavernosal artery: comparison of intraurethral instillation
and intracorporeal injection of prostaglandin E1. J Clin
Ultrasound 2001;29(5):273-278.
Knispel H H. Penile venous surgery in impotence: results in
highly selected cases. Urol Int 1991;47(3):144-148.
Kromann-Andersen B. Intracavernosal pharmacotherapy with
injection pen. Lancet 1988;1(8575-6):54-59.
Mansi M K, Alkhudair W K, Huraib S. Treatment of erectile
dysfunction after kidney transplantation with intracavernosal
self-injection of prostaglandin E1. Br J Urol 1998;159(6):1927­
1930.
McMahon C G. A pilot study of the role of intracavernous
injection of vasoactive intestinal peptide (VIP) and
phentolamine mesylate in the treatment of erectile dysfunction.
Int J Impot Res 1996;8(4):233-236.
McMahon C G. Priapism associated with concurrent use of
phosphodiesterase inhibitor drugs and intracavernous injection
therapy. Int J Impot Res 2003;15(5):383-384.
Metawea B, El-Nashar A R, Gad-Allah A et al. Intracavernous
papaverine/phentolamine-induced priapism can be accurately
predicted with color Doppler ultrasonography. Urology
2005;66(4):858-860.
Mirone V, Imbimbo C, Fabrizio F et al. Ketanserin plus
prostaglandin E1 (PGE-1) as intracavernosal therapy for patients
with erectile dysfunction unresponsive to PGE-1 alone. Br J
Urol 1996;77(5):736-739.
Nagai A, Kusumi N, Tsuboi H et al. Intracavernous injection of
prostaglandin E1 is effective in patients with erectile
dysfunction not responding to phosphodiseterase 5 inhibitors.
Acta Med Okayama 2005;59(6):279-280.
Nalesnik J G, Jones L, Kraus S R. Group B streptococcal
septicemia following intracavernous injection therapy for
erectile dysfunction in diabetes. Br J Urol 2004;172(1):151-152.
Pagani E, Puech-Leao P, Glina S et al. The value of a second
injection on the pharmaco-induced erection test. Int J Impot Res
1997;9(3):167-168.
Price D E, Cooksey G, Jehu D et al. The management of
impotence in diabetic men by vacuum tumescence therapy.
Diabet Med 1991;8(10):964-967.
Rodilla F, Fuentes M D, Chuan P et al. Penile selfinjection
for impotence in patients after radical
cystectomy. Journal of Clinical Pharmacy &
Therapeutics 1994;19(6):359-360.
Rodrigues M, Granegger S, O'Grady J et al.
Accumulation of platelets as a key mechanism of
human erection. A scintigraphic study in patients with
erectile dysfunction receiving intracavernous injection
of PGE1, papaverine/phentolamine. Advances in
Experimental Medicine & Biology 1997;43379-82.
Schouman M, Lacroix P, Amer M. Suppression of
prostaglandin E1-induced pain by dilution of the drug
with lidocaine before intracavernous injection. Br J
Urol 1992;148(4):1266
Sparwasser C, Treiber U, Bahren W et al.
Postoperative erectile dysfunction; evaluation and
treatment with intracavernous vasoactive injections.
Progress in Clinical & Biological Research
1991;370349-354.
Stief C G, Holmquist F, Djamilian M et al.
Preliminary results with the nitric oxide donor
linsidomine chlorhydrate in the treatment of human
erectile dysfunction. Br J Urol 1992;148(5):1437­
1440.
Stief C G, Wetterauer U, Schaebsdau F H et al.
Calcitonin-gene-related peptide: a possible role in
human penile erection and its therapeutic application
in impotent patients. Br J Urol 1991;146(4):1010­
1014.
Vickers M A, De Nobrega A M, Dluhy R G.
Diagnosis and treatment of psychogenic erectile
dysfunction in a urological setting: Outcomes of 18
consecutive patients. Br J Urol 1993;149(5
SUPPL.):1258-1261.
Weiss J N, Ravalli R, Badlani G H. Intracavernous
pharmacotherapy in psychogenic impotence. Urology
1991;37(5):441-443.
Observational injection study > or = to 6 months in
duration.
al-Juburi A Z, O'Donnell P D. Follow up outcome of
intracavernous papaverine. J Ark Med Soc
1990;86(10):383-385.
Armstrong D K, Convery A G, Dinsmore W W.
Reasons for patient drop-out from an intracavernous
auto-injection programme for erectile dysfunction. Br
J Urol 1994;74(1):99-101.
Chang D W, Wood C G, Kroll S S et al. Cavernous
nerve reconstruction to preserve erectile function
following non-nerve-sparing radical retropubic
prostatectomy: a prospective study. Keisei Geka
2003;111(3):1174-1181.
D-88